Pharmchem Stock Buy Hold or Sell Recommendation
| PCHM Stock | USD 3.05 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding PharmChem is 'Strong Sell'. The recommendation algorithm takes into account all of PharmChem's available fundamental, technical, and predictive indicators you will find on this site.
Check out PharmChem Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as PharmChem and provide practical buy, sell, or hold advice based on investors' constraints. PharmChem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
PharmChem |
Execute PharmChem Buy or Sell Advice
The PharmChem recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on PharmChem. Macroaxis does not own or have any residual interests in PharmChem or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute PharmChem's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
PharmChem Trading Alerts and Improvement Suggestions
| PharmChem generated a negative expected return over the last 90 days | |
| The company has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist PharmChem until it has trouble settling it off, either with new capital or with free cash flow. So, PharmChem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PharmChem sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PharmChem to invest in growth at high rates of return. When we think about PharmChem's use of debt, we should always consider it together with cash and equity. | |
| PharmChem reported the previous year's revenue of 26.45 M. Net Loss for the year was (2.15 M) with profit before overhead, payroll, taxes, and interest of 5.86 M. |
PharmChem Returns Distribution Density
The distribution of PharmChem's historical returns is an attempt to chart the uncertainty of PharmChem's future price movements. The chart of the probability distribution of PharmChem daily returns describes the distribution of returns around its average expected value. We use PharmChem price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of PharmChem returns is essential to provide solid investment advice for PharmChem.
| Mean Return | -0.22 | Value At Risk | -5.01 | Potential Upside | 4.17 | Standard Deviation | 2.93 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of PharmChem historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
PharmChem Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to PharmChem or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that PharmChem's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a PharmChem pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.21 | |
β | Beta against Dow Jones | -0.55 | |
σ | Overall volatility | 2.31 | |
Ir | Information ratio | -0.08 |
PharmChem Volatility Alert
PharmChem exhibits very low volatility with skewness of -1.02 and kurtosis of 8.77. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure PharmChem's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact PharmChem's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.PharmChem Fundamentals Vs Peers
Comparing PharmChem's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze PharmChem's direct or indirect competition across all of the common fundamentals between PharmChem and the related equities. This way, we can detect undervalued stocks with similar characteristics as PharmChem or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of PharmChem's fundamental indicators could also be used in its relative valuation, which is a method of valuing PharmChem by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare PharmChem to competition |
| Fundamentals | PharmChem | Peer Average |
| Return On Equity | -0.24 | -0.31 |
| Return On Asset | -0.0537 | -0.14 |
| Profit Margin | (0.08) % | (1.27) % |
| Operating Margin | (0.06) % | (5.51) % |
| Current Valuation | 17.56 K | 16.62 B |
| Price To Earning | (2.30) X | 28.72 X |
| Price To Book | 0 X | 9.51 X |
| Price To Sales | 0.0006 X | 11.42 X |
| Revenue | 26.45 M | 9.43 B |
| Gross Profit | 5.86 M | 27.38 B |
| Net Income | (2.15 M) | 570.98 M |
| Cash And Equivalents | 626 K | 2.7 B |
| Cash Per Share | 0.11 X | 5.01 X |
| Debt To Equity | 0.37 % | 48.70 % |
| Current Ratio | 0.69 X | 2.16 X |
| Book Value Per Share | 1.30 X | 1.93 K |
| Earnings Per Share | (0.35) X | 3.12 X |
| Number Of Employees | 11 | 18.84 K |
| Beta | 1.15 | -0.15 |
| Market Capitalization | 17.55 K | 19.03 B |
| Total Asset | 16.66 M | 29.47 B |
| Retained Earnings | (10.28 M) | 9.33 B |
| Working Capital | 1.28 M | 1.48 B |
| Current Asset | 6.8 M | 9.34 B |
| Current Liabilities | 5.52 M | 7.9 B |
| Z Score | 1.0 | 8.72 |
| Annual Yield | 0.03 % | |
| Five Year Return | 4.60 % | |
| Net Asset | 16.66 M |
PharmChem Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as PharmChem . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About PharmChem Buy or Sell Advice
When is the right time to buy or sell PharmChem? Buying financial instruments such as PharmChem Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having PharmChem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run CNY Crypto Assets Thematic Idea Now
CNY Crypto Assets
An experimental p2p digital currency that is accepted by many vendors in Chinese Yuan. The CNY Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize CNY Crypto Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in PharmChem Pink Sheet
PharmChem financial ratios help investors to determine whether PharmChem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PharmChem with respect to the benefits of owning PharmChem security.